Comments
The Competition Commission of India (CCI) on Tuesday approved Procter & Gamble Co’s acquisition of 51.8 per cent stake in pharma major Merck.
The acquisition is part of a larger deal between Mumbai-based Merck’s German parent and US-based Procter & Gamble Co. The deal had triggered a mandatory open offer under which P&G Overseas India BV along with P&G Co had offered to buy an additional 26 per cent from the public shareholders of Merck at ₹1,500.36 a share.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.